
Hemodialysis Vascular Grafts Market Report and Forecast 2025-2034
Description
The global hemodialysis vascular grafts market size was valued at USD 284.78 Million in 2024, driven by the increasing geriatric population across the globe. The market size is anticipated to grow at a CAGR of 5.20% during the forecast period of 2025-2034 to achieve a value of USD 472.79 Million by 2034.
Hemodialysis Vascular Grafts: Introduction
Arteriovenous (AV) graft is widely used for hemodialysis. The usual placement of graft is in the arm, but it can also be placed in the leg depending upon the situation. An AV graft is the connection of a vein and an artery that utilizes a hollow, synthetic tube (the actual “graft”). This connection enables high blood flow, high pressure artery through the graft and into the low flow, low pressure vein. Due to which, blood flow through the graft provides a flow rate delivering sufficient blood to provide an appropriate hemodialysis treatment.
Global Hemodialysis Vascular Grafts Market Analysis
The market for hemodialysis vascular grafts has been experiencing significant growth supported by various factors and is expected to steadily grow in coming years as well. The factors such as increasing technological advancement in hemodialysis therapy are majorly influencing the market growth. The advancements such as bioartificial kidneys, hemodiafiltration, wearable artificial kidneys, and portable machines are influencing the market and hemodialysis adoption by patients and healthcare professionals.
The key players are heavily investing in the research and development activities that are inclined towards creating more advanced technological equipment, medicinal drugs and therapies to treat chronic kidney diseases which is expected to further propel the global hemodialysis vascular grafts market growth. For example, Kidney Health Initiative and Kidney X: The Kidney Innovation Accelerator, as well as The Advancing American Kidney Health Initiative are collaborating to develop new therapies which could potentially customize the treatment of end-stage renal disease ESRD. The continuous research and development activities by key players in the market are directly contributing to the market expansion as well. For example, Xeltis is a key player targeted towards developing transformative implants to provide solutions to the patients of such chronic diseases has presented highly encouraging six-month data from its first-in-human (FIH) aXess vascular graft trial (NCT04898153). The data exhibited high patency rates (80% primary patency, 95% primary assisted patency, 100% secondary patency). A 0% infection rate and low re-intervention rates were encountered at the six months duration, resulting in a highly favorable safety profile.
Global Hemodialysis Vascular Grafts Market Segmentations
Hemodialysis Vascular Grafts Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Expanded Polytetrafluoroethylene (ePTFE)
Polyethylene Terephthalate (PET) Human Saphenous and Umbilical Veins
Autologous Vein Grafts
Bovine Grafts
Porcine Grafts
Others
Market Breakup by Diameters
The increasing prevalence of chronic kidney diseases worldwide is propelling the market growth. According to the National Kidney Foundation, nearly 10% of the global population is affected by chronic kidney disease (CKD) accounting for millions of deaths yearly. The increase in geriatric population globally is also a major factor, adding further growth to the global hemodialysis vascular grafts market share. With increasing age, people get more susceptible to kidney diseases due to various factors, such as cardiovascular diseases, hypertension, and diabetes, among others.
North America has been leading the global market and is expected to lead the global market for the forecast period as well. This growth of the region is expected to be driven by the presence of geriatric population, large patient pool suffering from chronic kidney diseases due to factors such as adoption of sedentary lifestyle, including alcohol consumption, and unhealthy dietary habits, among others.
Hemodialysis Vascular Grafts Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Hemodialysis Vascular Grafts: Introduction
Arteriovenous (AV) graft is widely used for hemodialysis. The usual placement of graft is in the arm, but it can also be placed in the leg depending upon the situation. An AV graft is the connection of a vein and an artery that utilizes a hollow, synthetic tube (the actual “graft”). This connection enables high blood flow, high pressure artery through the graft and into the low flow, low pressure vein. Due to which, blood flow through the graft provides a flow rate delivering sufficient blood to provide an appropriate hemodialysis treatment.
Global Hemodialysis Vascular Grafts Market Analysis
The market for hemodialysis vascular grafts has been experiencing significant growth supported by various factors and is expected to steadily grow in coming years as well. The factors such as increasing technological advancement in hemodialysis therapy are majorly influencing the market growth. The advancements such as bioartificial kidneys, hemodiafiltration, wearable artificial kidneys, and portable machines are influencing the market and hemodialysis adoption by patients and healthcare professionals.
The key players are heavily investing in the research and development activities that are inclined towards creating more advanced technological equipment, medicinal drugs and therapies to treat chronic kidney diseases which is expected to further propel the global hemodialysis vascular grafts market growth. For example, Kidney Health Initiative and Kidney X: The Kidney Innovation Accelerator, as well as The Advancing American Kidney Health Initiative are collaborating to develop new therapies which could potentially customize the treatment of end-stage renal disease ESRD. The continuous research and development activities by key players in the market are directly contributing to the market expansion as well. For example, Xeltis is a key player targeted towards developing transformative implants to provide solutions to the patients of such chronic diseases has presented highly encouraging six-month data from its first-in-human (FIH) aXess vascular graft trial (NCT04898153). The data exhibited high patency rates (80% primary patency, 95% primary assisted patency, 100% secondary patency). A 0% infection rate and low re-intervention rates were encountered at the six months duration, resulting in a highly favorable safety profile.
Global Hemodialysis Vascular Grafts Market Segmentations
Hemodialysis Vascular Grafts Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Synthetic Grafts
- Biological Grafts
Market Breakup by Diameters
- Small Diameter Grafts (4 to 6 mm)
- Large Diameter Grafts (6 to 10 mm)
- Straight Grafts
- Loop Grafts
- Hospitals
- Dialysis Centers
- Ambulatory Surgical Centers (ASCs)
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The increasing prevalence of chronic kidney diseases worldwide is propelling the market growth. According to the National Kidney Foundation, nearly 10% of the global population is affected by chronic kidney disease (CKD) accounting for millions of deaths yearly. The increase in geriatric population globally is also a major factor, adding further growth to the global hemodialysis vascular grafts market share. With increasing age, people get more susceptible to kidney diseases due to various factors, such as cardiovascular diseases, hypertension, and diabetes, among others.
North America has been leading the global market and is expected to lead the global market for the forecast period as well. This growth of the region is expected to be driven by the presence of geriatric population, large patient pool suffering from chronic kidney diseases due to factors such as adoption of sedentary lifestyle, including alcohol consumption, and unhealthy dietary habits, among others.
Hemodialysis Vascular Grafts Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- W. L. Gore & Associates, Inc.,
- C. R. Bard, Inc.
- Vascudyne, Inc.
- LeMaitre
- Getinge AB,
- VASCULAR GENESIS,
- InnAVasc Medical, Inc.
- CryoLife, Inc.
- Merit Medical Systems
- BIOVIC Sdn Bhd.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Hemodialysis Vascular Grafts Market Overview
- 3.1 Global Hemodialysis Vascular Grafts Market Historical Value (2018-2024)
- 3.2 Global Hemodialysis Vascular Grafts Market Forecast Value (2025-2034)
- 4 Global Hemodialysis Vascular Grafts Market Landscape
- 4.1 Global Hemodialysis Vascular Grafts Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Hemodialysis Vascular Grafts Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Diameter
- 4.2.3 Analysis by Configuration
- 5 Global Hemodialysis Vascular Grafts Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Hemodialysis Vascular Grafts Market Segmentation
- 6.1 Global Hemodialysis Vascular Grafts Market by Product
- 6.1.1 Market Overview
- 6.1.2 Synthetic Grafts
- 6.1.2.1 Expanded Polytetrafluoroethylene (ePTFE)
- 6.1.2.2 Polyethylene Terephthalate (PET)
- 6.1.3 Biological Grafts
- 6.1.3.1 Human Saphenous and Umbilical Veins
- 6.1.3.2 Autologous Vein Grafts
- 6.1.3.3 Bovine Grafts
- 6.1.3.4 Porcine Grafts
- 6.1.3.5 Others
- 6.2 Global Hemodialysis Vascular Grafts Market by Diameters
- 6.2.1 Market Overview
- 6.2.2 Small Diameter Grafts (4 to 6 mm)
- 6.2.3 Large Diameter Grafts (6 to 10 mm)
- 6.3 Global Hemodialysis Vascular Grafts Market by Configuration
- 6.3.1 Market Overview
- 6.3.2 Straight Grafts
- 6.3.3 Loop Grafts
- 6.4 Global Hemodialysis Vascular Grafts Market by End Use
- 6.4.1 Market Overview
- 6.4.2 Hospitals
- 6.4.3 Dialysis Centers
- 6.4.4 Ambulatory Surgical Centers (ASCs)
- 6.4.5 Others
- 6.5 Global Hemodialysis Vascular Grafts Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Hemodialysis Vascular Grafts Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Hemodialysis Vascular Grafts Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Hemodialysis Vascular Grafts Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Hemodialysis Vascular Grafts Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Hemodialysis Vascular Grafts Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 W. L. Gore & Associates, Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisition
- 17.1.5 Certifications
- 17.2 C. R. Bard, Inc.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisition
- 17.2.5 Certifications
- 17.3 Vascudyne, Inc.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisition
- 17.3.5 Certifications
- 17.4 LeMaitre
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisition
- 17.4.5 Certifications
- 17.5 Getinge AB
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisition
- 17.5.5 Certifications
- 17.6 VASCULAR GENESIS
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisition
- 17.6.5 Certifications
- 17.7 InnAVasc Medical, Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisition
- 17.7.5 Certifications
- 17.8 CryoLife, Inc.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisition
- 17.8.5 Certifications
- 17.9 Merit Medical Systems
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisition
- 17.9.5 Certifications
- 17.10 BIOVIC Sdn Bhd.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisition
- 17.10.5 Certifications
- 18 Global Hemodialysis Vascular Grafts Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.